| Primary |
| Bipolar Disorder |
33.3% |
| Diffuse Large B-cell Lymphoma |
25.0% |
| Hypothyroidism |
25.0% |
| Product Used For Unknown Indication |
8.3% |
| Thyroiditis Subacute |
8.3% |
|
| Syncope |
28.6% |
| Pneumonia |
14.3% |
| Procedural Haemorrhage |
14.3% |
| Respiratory Distress |
14.3% |
| Treatment Noncompliance |
14.3% |
| Upper Respiratory Tract Infection |
14.3% |
|
| Secondary |
| Product Used For Unknown Indication |
20.4% |
| Electrolyte Substitution Therapy |
12.4% |
| Hypertension |
10.2% |
| Drug Use For Unknown Indication |
6.6% |
| Hypothyroidism |
6.6% |
| Stupor |
6.6% |
| Arthritis |
5.8% |
| Bipolar Disorder |
4.4% |
| Pain |
4.0% |
| Depression |
3.3% |
| Hypotension |
2.6% |
| Restlessness |
2.6% |
| Ankylosing Spondylitis |
2.2% |
| Parkinson's Disease |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Constipation |
1.8% |
| Sepsis |
1.8% |
| Hyperglycaemia |
1.5% |
| Polyuria |
1.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.5% |
|
| Syncope |
28.6% |
| Toxic Epidermal Necrolysis |
12.2% |
| Vomiting |
8.2% |
| Procedural Haemorrhage |
6.1% |
| Renal Failure |
6.1% |
| Suicide Attempt |
6.1% |
| Lymphadenopathy |
4.1% |
| Pupillary Reflex Impaired |
4.1% |
| Angioedema |
2.0% |
| Atrial Fibrillation |
2.0% |
| Atrial Tachycardia |
2.0% |
| Blood Electrolytes Abnormal |
2.0% |
| Cardiac Failure |
2.0% |
| Coronary Artery Disease |
2.0% |
| Drug Abuse |
2.0% |
| Drug Interaction |
2.0% |
| Epilepsy |
2.0% |
| Local Swelling |
2.0% |
| Nephrotic Syndrome |
2.0% |
| Pancreatitis |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.0% |
| Drug Use For Unknown Indication |
15.9% |
| Hypertension |
11.6% |
| Hypothyroidism |
10.9% |
| Rheumatoid Arthritis |
7.2% |
| Breast Cancer |
3.5% |
| Depression |
3.4% |
| Prophylaxis |
2.5% |
| Pain |
2.4% |
| Atrial Fibrillation |
2.2% |
| Diabetes Mellitus |
2.2% |
| Epilepsy |
2.1% |
| Osteoporosis |
1.7% |
| Breast Cancer Metastatic |
1.7% |
| Glioblastoma |
1.5% |
| Metastatic Renal Cell Carcinoma |
1.5% |
| Renal Transplant |
1.5% |
| Chronic Myeloid Leukaemia |
1.4% |
| Hypopituitarism |
1.4% |
| Tumour Pain |
1.3% |
|
| Vomiting |
12.9% |
| Thrombocytopenia |
10.7% |
| Renal Failure Acute |
6.0% |
| Weight Decreased |
6.0% |
| General Physical Health Deterioration |
5.2% |
| Pulmonary Embolism |
4.7% |
| Renal Failure |
4.7% |
| Weight Increased |
4.7% |
| Respiratory Failure |
4.3% |
| Urinary Tract Infection |
4.3% |
| Pain In Extremity |
3.9% |
| Pyrexia |
3.9% |
| Somnolence |
3.9% |
| Syncope |
3.9% |
| Tremor |
3.9% |
| Myocardial Infarction |
3.4% |
| Sepsis |
3.4% |
| Tachycardia |
3.4% |
| Vertigo |
3.4% |
| Wrong Technique In Drug Usage Process |
3.4% |
|
| Interacting |
| Depression |
57.9% |
| Drug Use For Unknown Indication |
15.8% |
| Hypothyroidism |
15.8% |
| Hypertension |
10.5% |
|
| Status Epilepticus |
44.4% |
| Hypothyroidism |
22.2% |
| Drug Interaction |
11.1% |
| Hypertensive Crisis |
11.1% |
| Parosmia |
11.1% |
|
